HSDT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Helius Medical Technologies Inc (HSDT).


$2.50M Market Cap.

As of 03/25/2025 5:00 PM ET (MRY) • Disclaimer

HSDT Market Cap. (MRY)


HSDT Shares Outstanding (MRY)


HSDT Assets (MRY)


Total Assets

$3.54M

Total Liabilities

$2.48M

Total Investments

$0

HSDT Income (MRY)


Revenue

$520.00K

Net Income

-$11.74M

Operating Expense

$13.84M

HSDT Cash Flow (MRY)


CF Operations

-$11.04M

CF Investing

-$5.00K

CF Financing

$6.95M

HSDT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

HSDT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$3,542,000 (-53.95%)

$7,692,000 (-55.50%)

$17,287,000 (22.59%)

$14,102,000 (115.40%)

Assets Current

$3,424,000 (-53.97%)

$7,438,000 (-55.45%)

$16,697,000 (32.58%)

$12,594,000 (168.82%)

Assets Non-Current

$118,000 (-53.54%)

$254,000 (-56.95%)

$590,000 (-60.88%)

$1,508,000 (-19.01%)

Goodwill & Intangible Assets

$0 (0%)

$24,000 (-82.86%)

$140,000 (-87.23%)

$1,096,000 (-14.77%)

Shareholders Equity

$1,059,000 (-54.94%)

$2,350,000 (-71.17%)

$8,151,000 (-27.59%)

$11,256,000 (190.78%)

Property Plant & Equipment Net

$118,000 (-48.70%)

$230,000 (-48.89%)

$450,000 (9.22%)

$412,000 (-28.47%)

Cash & Equivalents

$1,088,000 (-79.00%)

$5,182,000 (-64.38%)

$14,549,000 (32.20%)

$11,005,000 (230.38%)

Accumulated Other Comprehensive Income

$333,000 (149.48%)

-$673,000 (-73.45%)

-$388,000 (65.51%)

-$1,125,000 (-2.37%)

Deferred Revenue

$118,000 (-30.99%)

$171,000 (-15.35%)

$202,000 (-40.76%)

$341,000 (-31.94%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$1,036,000 (126.70%)

$457,000 (-22.41%)

$589,000 (23.74%)

$476,000 (22.37%)

Trade & Non-Trade Receivables

$635,000 (-0.31%)

$637,000 (85.71%)

$343,000 (36.65%)

$251,000 (9.13%)

Trade & Non-Trade Payables

$873,000 (64.41%)

$531,000 (-15.31%)

$627,000 (-41.35%)

$1,069,000 (43.11%)

Accumulated Retained Earnings (Deficit)

-$171,699,000 (-7.34%)

-$159,957,000 (-5.86%)

-$151,107,000 (-10.27%)

-$137,035,000 (-15.25%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$12,000 (-78.95%)

$57,000 (-48.18%)

$110,000 (3566.67%)

$3,000 (-96.70%)

Debt Current

$12,000 (-73.33%)

$45,000 (-16.67%)

$54,000 (1700.00%)

$3,000 (-94.92%)

Debt Non-Current

$0 (0%)

$12,000 (-78.57%)

$56,000 (0%)

$0 (0%)

Total Liabilities

$2,483,000 (-53.52%)

$5,342,000 (-41.53%)

$9,136,000 (221.01%)

$2,846,000 (6.35%)

Liabilities Current

$2,163,000 (15.11%)

$1,879,000 (-5.48%)

$1,988,000 (-25.07%)

$2,653,000 (9.45%)

Liabilities Non-Current

$320,000 (-90.76%)

$3,463,000 (-51.55%)

$7,148,000 (3603.63%)

$193,000 (-23.41%)

HSDT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$520,000 (-19.25%)

$644,000 (-18.17%)

$787,000 (50.77%)

$522,000 (-21.03%)

Cost of Revenue

$582,000 (-0.17%)

$583,000 (25.92%)

$463,000 (55.37%)

$298,000 (-23.20%)

Selling General & Administrative Expense

$10,118,000 (9.14%)

$9,271,000 (-12.87%)

$10,640,000 (-12.61%)

$12,176,000 (25.34%)

Research & Development Expense

$3,659,000 (24.37%)

$2,942,000 (-30.97%)

$4,262,000 (-28.85%)

$5,990,000 (30.73%)

Operating Expenses

$13,841,000 (10.83%)

$12,489,000 (-21.16%)

$15,840,000 (-13.75%)

$18,366,000 (25.29%)

Interest Expense

$17,000 (106.61%)

-$257,000 (-130.82%)

$834,000 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$11,742,000 (-32.68%)

-$8,850,000 (37.11%)

-$14,072,000 (22.39%)

-$18,132,000 (-28.32%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$11,742,000 (-32.68%)

-$8,850,000 (37.11%)

-$14,072,000 (22.39%)

-$18,132,000 (-28.32%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$11,742,000 (-32.68%)

-$8,850,000 (37.11%)

-$14,072,000 (22.39%)

-$18,132,000 (-28.32%)

Weighted Average Shares

$2,709,781 (345.77%)

$607,890 (125.19%)

$269,943 (449.38%)

$49,136 (105.12%)

Weighted Average Shares Diluted

$2,709,781 (345.77%)

$607,890 (125.19%)

$269,943 (449.38%)

$49,136 (105.12%)

Earning Before Interest & Taxes (EBIT)

-$11,725,000 (-28.75%)

-$9,107,000 (31.21%)

-$13,238,000 (26.99%)

-$18,132,000 (-28.32%)

Gross Profit

-$62,000 (-201.64%)

$61,000 (-81.17%)

$324,000 (44.64%)

$224,000 (-17.95%)

Operating Income

-$13,903,000 (-11.87%)

-$12,428,000 (19.90%)

-$15,516,000 (14.47%)

-$18,142,000 (-26.11%)

HSDT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$5,000 (82.76%)

-$29,000 (-163.64%)

-$11,000 (80.36%)

-$56,000 (-522.22%)

Net Cash Flow from Financing

$6,954,000 (545.68%)

$1,077,000 (-93.97%)

$17,869,000 (-15.42%)

$21,126,000 (119.19%)

Net Cash Flow from Operations

-$11,041,000 (-6.00%)

-$10,416,000 (27.21%)

-$14,310,000 (-6.89%)

-$13,388,000 (-14.06%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$4,094,000 (56.29%)

-$9,367,000 (-364.31%)

$3,544,000 (-53.82%)

$7,674,000 (460.62%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$5,000 (82.76%)

-$29,000 (-163.64%)

-$11,000 (80.36%)

-$56,000 (-522.22%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$7,954,000 (596.50%)

$1,142,000 (-93.87%)

$18,644,000 (-22.37%)

$24,015,000 (125.43%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$2,000 (-300.00%)

$1,000 (125.00%)

-$4,000 (50.00%)

-$8,000 (57.89%)

Share Based Compensation

$2,522,000 (54.82%)

$1,629,000 (-28.80%)

$2,288,000 (-46.44%)

$4,272,000 (68.92%)

Depreciation Amortization & Accretion

$101,000 (-52.80%)

$214,000 (-30.07%)

$306,000 (-18.18%)

$374,000 (-47.10%)

HSDT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-11.90% (-225.26%)

9.50% (-76.94%)

41.20% (-3.96%)

42.90% (3.87%)

Profit Margin

-2258.10% (-64.32%)

-1374.20% (23.15%)

-1788.10% (48.52%)

-3473.60% (-62.49%)

EBITDA Margin

-2235.40% (-61.88%)

-1380.90% (15.96%)

-1643.20% (51.70%)

-3401.90% (-67.52%)

Return on Average Equity (ROAE)

-356.30% (-61.15%)

-221.10% (-28.62%)

-171.90% (13.36%)

-198.40% (34.46%)

Return on Average Assets (ROAA)

-197.90% (-129.58%)

-86.20% (19.89%)

-107.60% (29.72%)

-153.10% (19.46%)

Return on Sales (ROS)

-2254.80% (-59.45%)

-1414.10% (15.93%)

-1682.10% (51.57%)

-3473.60% (-62.49%)

Return on Invested Capital (ROIC)

-2411.30% (-85.14%)

-1302.40% (38.53%)

-2118.90% (-148.21%)

4395.60% (116.88%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.15 (71.92%)

-0.55 (-87.12%)

-0.29 (58.04%)

-0.7 (37.06%)

Price to Sales Ratio (P/S)

3.49 (-53.97%)

7.59 (44.18%)

5.26 (-78.45%)

24.43 (2.27%)

Price to Book Ratio (P/B)

2.36 (-2.60%)

2.42 (128.15%)

1.06 (-3.80%)

1.1 (-78.14%)

Debt to Equity Ratio (D/E)

2.35 (3.17%)

2.27 (102.77%)

1.12 (343.08%)

0.25 (-63.39%)

Earnings Per Share (EPS)

-4.33 (70.26%)

-14.56 (72.00%)

-52 (85.91%)

-369 (37.46%)

Sales Per Share (SPS)

0.19 (-81.87%)

1.06 (-63.67%)

2.92 (-72.56%)

10.62 (-61.50%)

Free Cash Flow Per Share (FCFPS)

-4.08 (76.28%)

-17.18 (67.61%)

-53.05 (80.61%)

-273.61 (44.20%)

Book Value Per Share (BVPS)

0.39 (-89.89%)

3.87 (-87.20%)

30.2 (-86.82%)

229.08 (41.77%)

Tangible Assets Book Value Per Share (TABVPS)

1.31 (-89.64%)

12.61 (-80.14%)

63.52 (-76.00%)

264.7 (20.53%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

1 (0%)

0 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.08 (-13.83%)

0.09 (-84.56%)

0.61 (239.04%)

-0.44 (65.48%)

Asset Turnover

0.09 (39.68%)

0.06 (5.00%)

0.06 (36.36%)

0.04 (-50.56%)

Current Ratio

1.58 (-60.01%)

3.96 (-52.88%)

8.4 (76.93%)

4.75 (145.58%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$11,046,000 (-5.75%)

-$10,445,000 (27.07%)

-$14,321,000 (-6.52%)

-$13,444,000 (-14.45%)

Enterprise Value (EV)

-$946,006 (-13.67%)

-$832,261 (89.44%)

-$7,879,408 (-201.41%)

$7,769,841 (-54.37%)

Earnings Before Tax (EBT)

-$11,742,000 (-32.68%)

-$8,850,000 (37.11%)

-$14,072,000 (22.39%)

-$18,132,000 (-28.32%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$11,624,000 (-30.71%)

-$8,893,000 (31.23%)

-$12,932,000 (27.18%)

-$17,758,000 (-32.30%)

Invested Capital

$303,000 (-54.37%)

$664,000 (-7.78%)

$720,000 (210.94%)

-$649,000 (-61.04%)

Working Capital

$1,261,000 (-77.32%)

$5,559,000 (-62.21%)

$14,709,000 (47.96%)

$9,941,000 (339.67%)

Tangible Asset Value

$3,542,000 (-53.81%)

$7,668,000 (-55.28%)

$17,147,000 (31.84%)

$13,006,000 (147.22%)

Market Capitalization

$2,498,994 (-56.11%)

$5,693,739 (-34.22%)

$8,655,592 (-30.33%)

$12,422,841 (-36.47%)

Average Equity

$3,295,750 (-17.66%)

$4,002,500 (-51.11%)

$8,186,000 (-10.43%)

$9,139,500 (95.78%)

Average Assets

$5,932,500 (-42.20%)

$10,263,500 (-21.52%)

$13,077,500 (10.45%)

$11,840,500 (59.26%)

Invested Capital Average

$486,250 (-30.46%)

$699,250 (11.92%)

$624,750 (251.45%)

-$412,500 (-860.37%)

Shares

3,728,172 (426.39%)

708,247 (25.56%)

564,066 (1078.28%)

47,872 (61.35%)